Allogeneic Valve Transplantation

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Boston Children's Hospital
Study ID
NCT06387446
Status
Recruiting
Apply to this trial

Conditions

  • Valve Disease, Aortic
  • Valve Disease, Heart
  • Valve Heart Disease

Eligibility Criteria

Sex
ALL
Age
30 Days - 50 Years
Healthy Volunteers
Not accepted

Interventions

  • Valve transplant — PROCEDURE
    Heart valves from an organ donor will be transplanted into recipient

Study Details

Valves will be taken from hearts donated by organ donors, and implanted into patients who need a new heart valve.

Key Dates

Start date
May 1, 2024
Status verified
Sep 2024
Primary completion
Jun 1, 2027
Completion
Jun 1, 2027

Study Design

Enrollment
4 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Valve transplantation group
    This arm undergoes Allogeneic Valve transplantation

Primary Outcome Measure

Valve Regurgitation [ Time Frame: One year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Boston Children's HospitalBostonMassachusetts02115
Sitaram Emani, MD

Find similar trials in Boston, MA

By research site
Boston Children's Hospital· Boston, MA

Related Studies